| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd72346bcce28340209c938e1f72e4be |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate |
2020-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82d5ad430ba6539b8ccf70f0c0e74441
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56dcc86c3721d8f854552bb2167d5cf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71b49e7b342ad6982830b1e4dc090de5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80c0f7c400f3b60c80705509871faaec |
| publicationDate |
2022-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3999027-A1 |
| titleOfInvention |
Pharmaceutical composition of imatinib |
| abstract |
The present invention relates to a pharmaceutical composition comprising imatinib or its pharmaceutically acceptable salt thereof and one or more pharmaceutical acceptable excipients in powder form, which can be reconstituted with a diluent just before administration. Further, the present invention provides process for the preparation of the said composition and its use for the treatment of cancer in pediatric patients. |
| priorityDate |
2019-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |